A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

[featured_image]
  • Version
  • Download 3
  • File Size 1.09 MB
  • File Count 1
  • Create Date October 9, 2020
  • Last Updated October 20, 2020

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study